March 9, 2022
Life Sciences
  • Pfizer Inc. said it began testing its antiviral pill to treat COVID-19 among children at high risk of severe illness. The study seeks to measure whether the pill can keep newly infected kids out of the hospital. Trial results are expected by the end of the year, and if they’re positive, Pfizer’s pill would be the first available for children under 12, making it particularly useful for those who aren’t vaccinated. (Article here)